Oncology
Precision medicine takes a village, with Carolyn Sousa and H...
In this interview with pharmaphorum, J&J's Henar Hevia and Carolyn Sousa, share their some of the company's data wins at the show and talk trends.
Market Access
Approval designed from day one: Building global-ready regula...
The global pharmaceutical landscape is increasingly defined by the necessity for clinical acceleration without compromising data integrity.
Patients
Towards a healthier world: Momentum in UK health system tran...
In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Lee-Ann Farrell, Head of National Programmes at Johnson & Johnson.
R&D
Changing Faces: Boards of Directors and Advisory Boards – Ap...
Boardrooms and advisory panels across biotech, pharma, digital health, and life sciences suppliers saw a wave of high‑profile additions in April.
Digital
Sponsored
The content velocity trap: Why producing more is making your...
Viseven explores how to fix the broken upstream engagement strategy process without losing even more time, resources, and effort in the process.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
